Author Archive: Roy Zwahlen

Roy Zwahlen

Roy is Associate Counsel at BIO and the main contributor for Patently Biotech. He is a lawyer by training, with a background in international and national politics. He grew up in the developing world and believes that innovation can and does solve many of the world’s problems. Because of this, his work focuses on creating a worldwide policy environment that fosters innovation in the biotechnology sector to prevent and cure diseases such as HIV, to increase crop yields to feed more people, and to decrease the harmful effects of industry on the environment. Roy spends his free time keeping up with his three kids, a wife that knows everything (no joke), and serving in his church and broader community. Learn more about Roy from his Linkedin Profile.

Latest Posts

Burrill Report’s interview with BIO’s President & CEO

Check out the new podcast on patent reform from Danny Levine of Burrill & Company at the Burrill Report blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Patent reform and Re-examination

Patent reform legislation was introduced in the House and Senate last week. Tell BIO what you think of the expansion of re-examination proceedings.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Tomorrow’s Senate hearing on Patent Reform

Tomorrow morning, the Senate Judiciary Committee will hold its first 2009 hearing on patent reform. If you have a minute, learn about past legislative efforts by visiting http://www.bio.org/ip/domestic/. Read the 5 Fact Sheets about last year’s legislation and take our poll:    [polldaddy poll=1439462]   To attend the hearing here in DC, or watch the webcast, visit http://www.judiciary.senate.gov/hearings/hearing.cfm?id=3701 for more information.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

BIO President & CEO James Greenwood Hosts Media Briefing

Take a look at a recent post at one of PatentlyBIOtech’s sister blogs: www.biotech-now.org. Last week, BIO’s President & CEO James Greenwood discussed patent reform, as well as other critical areas of legislative activity, impacting biotechnology researchers and companies in the United States. Visit Biotech Now and download or listen to the podcast: http://biotech-now.org/2009/03/06/bios-jim-greenwood-briefs-media-on-biotech-issues/.  

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

Why Stop at Better? Let’s Strive For What’s Best (for Everyone)

BIO President and CEO Jim Greenwood responsed to a blog post on patent reform today. You can read it before it hits the blogosphere at PatentlyBIOtech blog.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,